Holen Sie sich die Stockscreener-App
214.42
0.73%
1.55
Handel nachbörslich:
218.70
4.28
+2.00%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt STE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$212.87
Offen:
$212.17
24-Stunden-Volumen:
794.74K
Relative Volume:
0.98
Marktkapitalisierung:
$21.03B
Einnahmen:
$5.94B
Nettoeinkommen (Verlust:
$785.30M
KGV:
27.02
EPS:
7.9343
Netto-Cashflow:
$972.40M
1W Leistung:
+1.69%
1M Leistung:
-5.04%
6M Leistung:
-15.82%
1J Leistung:
-15.10%
1-Tages-Spanne:
$210.57
$216.19
1-Wochen-Bereich:
$207.79
$217.82
52-Wochen-Spanne:
$195.14
$269.44
Steris Plc Stock (STE) Company Profile
Firmenname
Steris Plc
Sektor
Branche
Telefon
35312322000
Adresse
70 SIR JOHN ROGERSON'S QUAY, DUBLIN
Compare STE vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STE
Steris Plc
|
214.42 | 20.88B | 5.94B | 785.30M | 972.40M | 7.9343 |
ABT
Abbott Laboratories
|
88.82 | 153.12B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
317.75 | 120.08B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.58 | 99.27B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.81 | 83.12B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.16 | 47.44B | 6.30B | 1.07B | 1.09B | 1.8406 |
Steris Plc Stock (STE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-05-29 | Eingeleitet | Jefferies | Hold |
| 2024-10-24 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2023-05-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-04-14 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-23 | Herabstufung | Needham | Buy → Hold |
| 2022-07-14 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-07 | Eingeleitet | Wolfe Research | Outperform |
| 2021-05-26 | Hochstufung | Needham | Hold → Buy |
| 2021-02-04 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-09 | Eingeleitet | Needham | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2018-01-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-06-05 | Herabstufung | Wellington Shields | Gradually Accumulate → Hold |
| 2017-05-03 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2016-11-30 | Eingeleitet | Goldman | Neutral |
| 2016-06-03 | Hochstufung | Northcoast | Neutral → Buy |
| 2015-06-12 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2013-05-07 | Herabstufung | Griffin Securities | Buy → Hold |
| 2013-02-08 | Bestätigt | Griffin Securities | Buy |
| 2012-08-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2012-02-08 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2011-11-03 | Bestätigt | JMP Securities | Mkt Outperform |
| 2011-02-09 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-12-21 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-09-17 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2010-04-07 | Bestätigt | CL King | Strong Buy |
| 2010-03-26 | Eingeleitet | CL King | Strong Buy |
| 2010-03-03 | Eingeleitet | Brean Murray | Hold |
Alle ansehen
Steris Plc Aktie (STE) Neueste Nachrichten
Steris stock (IE00BFY8C754): earnings update and long-term hygiene demand - AD HOC NEWS
STERIS Plc (STE) Stock Analysis: Healthcare Giant With 21% Upside Potential - DirectorsTalk Interviews
Steris anticipates 7%-8% revenue growth and $11.10-$11.30 EPS in fiscal 2027 as board authorizes $1B buyback - MSN
Steris plc stock (IE00BFY8C754): Revenue momentum and analyst targets stay in focus - AD HOC NEWS
Steris PLC stock outperforms competitors on strong trading day - MSN
STERIS plc stock (US8589121081): Institutional buying highlights infection-prevention specialist - AD HOC NEWS
Dana Investment Advisors Inc. Acquires 39,753 Shares of STERIS plc $STE - MarketBeat
Number of shareholders of STERIS plc (Ireland) – NYSE:STE - TradingView
Steris PLC stock outperforms competitors despite losses on the day - MarketWatch
Sterilization Technology Market Is Going to Boom |• Steris Corporation • 3M Company • Getinge AB - openPR.com
STERIS Q4 Earnings Call Highlights - MarketBeat
Steris plc stock (IE00BFY8C754): steady growth story after latest earnings - AD HOC NEWS
Earnings call transcript: STERIS Q4 2026 sees strong revenue, EPS miss - Investing.com India
Earnings call transcript: STERIS Q4 2026 sees strong revenue, EPS miss By Investing.com - Investing.com South Africa
How Investors May Respond To STERIS (STE) Record FY26 Results And US$1 Billion Buyback Plan - simplywall.st
New STERIS (STE) director Pierre Boulud files initial Form 3 ownership report - Stock Titan
Steris bets big on Mentor with new $60M plant and U.S. consolidation plan - Crain's Cleveland Business
Steris plc stock (IE00BFY8C754): Shares up 1.41% to $230.46 on Jul 25 - AD HOC NEWS
Steris stock (IE00BFY8C754): Q4 earnings miss, analyst targets cut - AD HOC NEWS
STE Maintained by Keybanc -- Price Target Lowered to $269 - GuruFocus
KeyBanc cuts STERIS stock price target on lower peer multiples - Investing.com
KeyBanc cuts STERIS stock price target on lower peer multiples By Investing.com - Investing.com Nigeria
Stephens Adjusts Price Target on STERIS to $270 From $300, Maintains Overweight Rating - marketscreener.com
Jefferies Adjusts Price Target on STERIS to $225 From $253, Maintains Hold Rating - marketscreener.com
KeyBanc Adjusts Price Target on STERIS to $269 From $291, Maintains Overweight Rating - marketscreener.com
Piper Sandler Adjusts Price Target on STERIS to $270 From $300, Maintains Overweight Rating - Moomoo
Steris stock (IE00BFY8C754): Q4 revenue beats but EPS misses guidance - AD HOC NEWS
KeyBanc Maintains Steris PLC(STE.US) With Buy Rating, Cuts Target Price to $269 - Moomoo
Needham Maintains Steris PLC(STE.US) With Hold Rating - Moomoo
What To Expect From STERIS’s (STE) Q1 Earnings - Yahoo Finance UK
Steris Earnings: Sensible Share Buyback Plan and Promising Guidance for Fiscal 2027; FVE Increased - Morningstar
Higher Near-Term Revenue Forecasts and Expanding Margins Lift Steris' Fair Value Estimate - Morningstar
Steris PLC (STE) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook By GuruFocus - Investing.com Canada
STERIS Plc Experiences Valuation Adjustment Amid Competitive Pharmaceuticals Landscape - Markets Mojo
Piper Sandler Maintains Steris PLC(STE.US) With Buy Rating, Maintains Target Price $300 - Moomoo
Steris PLC (STE) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook - GuruFocus
Research Alert: CFRA Retains Buy Rating On Steris Plc - Moomoo
STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading - TradingView
Earnings call transcript: STERIS Q4 2026 revenue beats, EPS misses slightly - Investing.com Nigeria
Earnings call transcript: STERIS Q4 2026 revenue beats, EPS misses slightly By Investing.com - Investing.com South Africa
State Street (STE) reports 5.1% stake in STERIS PLC in Schedule 13G - Stock Titan
STERIS climbs after full-year results, new $1B buyback, and upbeat FY2027 outlook - Quiver Quantitative
Steris 4Q Cont Ops EPS $2.24 >STE - Moomoo
Transcript: Steris Q4 2026 Earnings Conference Call - Benzinga
Q4 2026 STERIS plc Earnings Call Transcript - GuruFocus
STERIS plc Q4 2026 Earnings Call Summary - Yahoo Finance
Steris 4Q Adj EPS $2.83 >STE - Moomoo
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of STERIS plc (NYSE:STE) - MarketBeat
Finanzdaten der Steris Plc-Aktie (STE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):